Showing results (41-50 of 907) with videos related to
Sort By:
Pageof 91
The American Journal of Medicine|November 29, 1985
Ticarcillin plus clavulanic acid in the treatment of patients with cancerV Fainstein, L Elting, S Pitlik, et al.Antimicrobial Agents and Chemotherapy|April 1, 1982
Comparative in vitro study of temocillin (BRL 17421), a new penicillinR Bolivar, S S Weaver, G P BodeyThe Journal of Antimicrobial Chemotherapy|January 1, 1985
Cefotaxime: single agent therapy for infections in cancer patients with adequate granulocyte countsK Rolston, R Bolivar, V Fainstein, et al.Journal of Clinical Microbiology|July 1, 1982
Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patientsG F Araj, R L Hopfer, S Chesnut, et al.Diagnostic Microbiology and Infectious Disease|June 1, 1984
Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organismsR Bolivar, S S Weaver, G P BodeyAntimicrobial Agents and Chemotherapy|February 1, 1978
Clinical pharmacology of mezlocillinB F Issell, G P Bodey, S WeaverCancer|July 15, 1987
Imipenem/cilastatin therapy of infections in cancer patientsG P Bodey, L Elting, P Jones, et al.The American Journal of Medicine|October 30, 1984
Systemic candidiasis in cancer patientsA W Maksymiuk, S Thongprasert, R Hopfer, et al.The Journal of Infectious Diseases|February 1, 1994
A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancerK V Rolston, H Nguyen, G Amos, et al.Archives of Internal Medicine|July 1, 1986
Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillinP G Jones, S V Strother, K V Rolston, et al.Pageof 91